Overview

The Director, Global Value Evidence Strategy is responsible for leading global value evidence strategy for assigned nephrology/immunology asset(s). This role provides strategic input into integrated evidence plans and leads evidence generation to support value demonstration, market access, reimbursement, and patient access objectives. The position also leads the Value Evidence Sub-Committee for relevant products and indications globally, reporting to the Executive Director, Global Value Evidence.

Responsibilities

• •Lead and coordinate health technology and value evidence input into clinical development programs
• •Serve on product development committee and support the Executive Director for tasks related to internal and/or alliance governance committees
• •Lead the Value Evidence Sub-Committee
• •Serve as Value Evidence lead in development and maintenance of the Integrated Evidence Plan (IEP)
• •Develop the global value evidence strategy accounting for payer (including HTA agencies), provider, patient, and policy maker evidence needs
• •Assess HTA needs for the assigned product and disease area and track methodological needs
• •Complete all global deliverables for assigned product/indication to support HTA and reimbursement submissions, including economic models, real world evidence, evidence synthesis and meta-analysis, global HTA statistical analysis plans, global value dossiers, and AMCP-format dossiers
• •Coordinate and provide scientific support for HTA submissions outside the US with subsidiaries
• •Lead company responses to HTA evaluations in the US (e.g., ICER)
• •Develop and generate post-approval real world evidence in collaboration with external researchers and experts
• •Develop a comprehensive publication and communication plan including presentation and publication of key value evidence at scientific conferences and peer-reviewed journals

Qualifications

• •Minimum 6 years (PhD/MD/PharmD) or 12 years (Master's degree) of relevant pharmaceutical company or payer experience in access, outcomes research, health economics, observational studies, health technology assessment, or related area
• •Late stage drug development and launch experience
• •Experience with evidence generation in rare diseases
• •PhD or Master's in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration, or related field; OR MD or PharmD

Competencies

• •Accountability for Results: Stay focused on key strategic objectives, be accountable for high standards of performance, and take an active role in leading change
• •Strategic Thinking and Problem Solving: Make decisions considering the long-term impact to customers, patients, employees, and the business
• •Patient and Customer Centricity: Maintain an ongoing focus on the needs of customers and/or key stakeholders
• •Impactful Communication: Communicate with logic, clarity, and respect; influence at all levels to achieve the best results
• •Respectful Collaboration: Seek and value others' perspectives and strive for diverse partnerships
• •Empowered Development: Play an active role in professional development as a business imperative

Compensation

Minimum $186,489 - Maximum $278,875, plus incentive opportunity. Actual pay will be determined based on job experience, specific skills, and comparison to internal incumbents. Comprehensive benefits including medical, dental, vision, prescription drug coverage, life insurance, disability insurance, 401(k) match, tuition reimbursement, student loan assistance, flexible time off, paid holidays, and paid leave programs.